Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing iopromide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |
iopromid 150 mg(I)/ml infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 240 mg (I)/ml infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg(I)/ml infusionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg (I)/ml infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
Iopromide 150 mg i/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
Iopromide 240 mg i/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
Iopromide 300 mg i/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
Iopromide 370 mg i/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 150 mg i/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 240 mg i/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg i/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 240 mg i/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg i/ml injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg i/ml injektionsvæske, opløsning, flaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 240 mg i/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg i/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg i/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg i/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg (I)/ml infusionsvæske, opløsning, flaske a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 150 mg(I)/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 240 mg(I)/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 300 mg(I)/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
iopromid 370 mg(I)/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopromide (substance) |
Inferred relationship |
Some |
|
Iopromide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iodine (as iopromide) 370 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |
Product containing iopromide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |
Product containing only iopromide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iodine (as iopromide) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |
Iodine (as iopromide) 240 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopromide (substance) |
Inferred relationship |
Some |
1 |